Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance

2005 ◽  
Vol 12 (4) ◽  
pp. 398-404 ◽  
Author(s):  
D. N. Moskovitz ◽  
C. Osiowy ◽  
E. Giles ◽  
G. Tomlinson ◽  
E. J. Heathcote
Keyword(s):  
Drug Resistance ◽  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Lamivudine Treatment ◽  
Severe Chronic Hepatitis

Long-term lamivudine treatment in anti-HBe positive chronic hepatitis B: an interim analysis

2001 ◽  
Vol 34 ◽  
pp. 132-133
Author(s):  
T. Santantonio ◽  
E. Sinisi ◽  
M. Mazzola ◽  
M. Insalata ◽  
A. Guastadisegni ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Interim Analysis ◽  
Lamivudine Treatment ◽  
Positive Chronic Hepatitis

Long-term safety of lamivudine treatment in patients with chronic hepatitis B

2003 ◽  
Vol 125 (6) ◽  
pp. 1714-1722 ◽  
Author(s):  
Anna S.F Lok ◽  
Ching-Lung Lai ◽  
Nancy Leung ◽  
Guang-Bi Yao ◽  
Zhen-Yu Cui ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Lamivudine Treatment
Sign in / Sign up

Export Citation Format

Share Document